Invesco’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-65,308
| Closed | -$807K | – | 3842 |
|
|
2024
Q4 | $807K | Sell |
65,308
-388,480
| -86% | -$4.45M | ﹤0.01% | 3001 |
|
|
2024
Q3 | $5.16M | Buy |
453,788
+360,501
| +386% | +$3.62M | ﹤0.01% | 2205 |
|
|
2024
Q2 | $666K | Buy |
93,287
+29,486
| +46% | +$226K | ﹤0.01% | 3156 |
|
|
2024
Q1 | $427K | Buy |
63,801
+40,888
| +178% | +$281K | ﹤0.01% | 3401 |
|
|
2023
Q4 | $149K | Sell |
22,913
-205,413
| -90% | -$1.32M | ﹤0.01% | 3618 |
|
|
2023
Q3 | $2.16M | Sell |
228,326
-1,032,308
| -82% | -$12.4M | ﹤0.01% | 2568 |
|
|
2023
Q2 | $17.6M | Sell |
1,260,634
-300,348
| -19% | -$5.12M | ﹤0.01% | 1435 |
|
|
2023
Q1 | $29.3M | Sell |
1,560,982
-641,964
| -29% | -$10.5M | 0.01% | 1165 |
|
|
2022
Q4 | $30.3M | Buy |
2,202,946
+494,557
| +29% | +$7.57M | 0.01% | 1156 |
|
|
2022
Q3 | $32.7M | Buy |
1,708,389
+31,938
| +2% | +$582K | 0.01% | 1078 |
|
|
2022
Q2 | $25.6M | Sell |
1,676,451
-30,240
| -2% | -$447K | 0.01% | 1231 |
|
|
2022
Q1 | $34.8M | Buy |
1,706,691
+12,340
| +0.7% | +$251K | 0.01% | 1182 |
|
|
2021
Q4 | $49.4M | Buy |
1,694,351
+494,638
| +41% | +$14.2M | 0.01% | 1049 |
|
|
2021
Q3 | $25.9M | Sell |
1,199,713
-48,379
| -4% | -$1.17M | 0.01% | 1397 |
|
|
2021
Q2 | $32M | Buy |
1,248,092
+656,730
| +111% | +$14M | 0.01% | 1316 |
|
|
2021
Q1 | $10.8M | Buy |
591,362
+212,881
| +56% | +$3.54M | ﹤0.01% | 1902 |
|
|
2020
Q4 | $4.37M | Buy |
378,481
+250,434
| +196% | +$2.29M | ﹤0.01% | 2262 |
|
|
2020
Q3 | $976K | Buy |
+128,047
| New | +$970K | ﹤0.01% | 2830 |
|
|
2020
Q1 | – | Sell |
-138,116
| Closed | -$1.06M | – | 3743 |
|
|
2019
Q4 | $1.06M | Buy |
+138,116
| New | +$806K | ﹤0.01% | 2970 |
|
|
2019
Q2 | – | Sell |
-12,109
| Closed | -$51K | – | 3791 |
|
|
2019
Q1 | $51K | Sell |
12,109
-11,864
| -49% | -$48.4K | ﹤0.01% | 3696 |
|
|
2018
Q4 | $98K | Sell |
23,973
-2,984
| -11% | -$15.6K | ﹤0.01% | 3655 |
|
|
2018
Q3 | $185K | Sell |
26,957
-473
| -2% | -$2.8K | ﹤0.01% | 3713 |
|
|
2018
Q2 | $108K | Buy |
+27,430
| New | +$95.2K | ﹤0.01% | 3769 |
|
|
2015
Q3 | – | Sell |
-571
| Closed | -$5K | – | 4022 |
|
|
2015
Q2 | $5K | Buy |
+571
| New | +$5.49K | ﹤0.01% | 4224 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 4316 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 4383 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 4344 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 4293 |
|
Other funds holding CDMO
Invesco's CDMO Position: Q1 2025 in Review
Invesco sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 65,308 shares — an estimated $807K sold.
Invesco first reported a position in CDMO in Q2 2015 and held it in 24 quarters. The position peaked at $49.4M in Q4 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Invesco reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Invesco sold 65,308 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $807K.
- Invesco first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2015 and held it in 24 quarters.
- Invesco's Avid Bioservices, Inc. Common Stock position peaked at $49.4M in Q4 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Invesco's 13F filing for Q1 2025, filed 12 May 2025.